Paper6869409
Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment.
Rynes RI. Am J Med, 1983. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment. Papers, record 6869409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6869409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Hydroxychloroquine | Major topic |
| Retinal Diseases | Major topic |
| Adult | |
| Aged | |
| Drug Evaluation | |
| Humans | |
| Middle Aged | |
| Ophthalmoscopy | |
| Scotoma | |
| Time Factors | |
| Visual Acuity | |
| Visual Fields |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37324471 | Hydroxychloroquine-induced Retinal Toxicity. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37324471 | PubMed |
| 32674481 | Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32674481 | PubMed |
| 27402071 | Hydroxychloroquine-induced retinopathy in a 57-year-old woman. | CMAJ | 2017 | https://conductscience.org/library/papers/27402071 | PubMed |
| 26493438 | Detection of Hydroxychloroquine Retinal Toxicity by Automated Perimetry in 60 Rheumatoid Arthritis Patients with Normal Fundoscopic Findings. | Glob J Health Sci | 2015 | https://conductscience.org/library/papers/26493438 | PubMed |
| 25114499 | Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy. | Clin Ophthalmol | 2014 | https://conductscience.org/library/papers/25114499 | PubMed |
| 24062937 | Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review. | Eur Heart J Acute Cardiovasc Care | 2013 | https://conductscience.org/library/papers/24062937 | PubMed |
| 21264010 | Adverse reactions to chloroquine and amodiaquine as used for malaria prophylaxis: a review of the literature. | Can Fam Physician | 1987 | https://conductscience.org/library/papers/21264010 | PubMed |
| 16249962 | Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. | Doc Ophthalmol | 2005 | https://conductscience.org/library/papers/16249962 | PubMed |
| 11548909 | A clinical and economic review of disease-modifying antirheumatic drugs. | Pharmacoeconomics | 2001 | https://conductscience.org/library/papers/11548909 | PubMed |
| 6426922 | Current status of disease-modifying drugs in progressive rheumatoid arthritis. | Drugs | 1984 | https://conductscience.org/library/papers/6426922 | PubMed |
| 3929938 | Screening for antimalarial maculopathy in rheumatology clinics. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/3929938 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6869409
GET https://conductscience.org/api/papers/v1/6869409/authors